J&J's proposed rebate model was a key topic of discussion at a Wednesday panel led by moderator, 340B Report Publisher and CEO Ted Slafsky.
Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.